Luteal progesterone level correlated with immunotherapy success of patients with repeated implantation failures
O. Sefrioui, A. Madkour, N. Bouamoud, I. Kaarouch, B. Saadani, S. Amzazi, H. Copin, M. Benkhalifa, N. Louanjli
This study shows that immunotherapy with PBMCs improves clinical outcomes and correlates with higher luteal progesterone levels in RIF patients.
bioRxiv · Apr 9, 2019 · PreprintImmunology